|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.18 USD | -1.87% |
|
+5.69% | +38.96% |
| Dec. 03 | Pacira Biosciences reports inducement grants under Nasdaq Listing Rule | RE |
| Dec. 02 | Pacira Says Iovera Outperformed Radiofrequency Ablation in Chronic Low Back Pain | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Drug Delivery Systems | 430M | 542M | 667M | 675M | 701M | |||||
Total Assets | 1.27B | 2.08B | 1.68B | 1.57B | 1.55B | |||||
Interest Expense | -25.67M | -31.75M | -39.98M | -20.31M | -16.57M | |||||
Income Tax Expense | -125M | 14.42M | -2.61M | 19.75M | 36.45M | |||||
CAPEX | -37.8M | -45.87M | -30.08M | -15.16M | -10.64M | |||||
EBT | 20.09M | 56.4M | 13.3M | 61.7M | -63.11M | |||||
D&A | 19.91M | 28.55M | 81M | 75.57M | 78.78M | |||||
Operating Income | 46.35M | 89.92M | 60.02M | 87.68M | -73.37M | |||||
Net Income | 146M | 41.98M | 15.91M | 41.96M | -99.56M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 430M | 542M | 667M | 675M | 701M | |||||
Total Assets | 1.27B | 2.08B | 1.68B | 1.57B | 1.55B | |||||
Interest Expense | -25.67M | -31.75M | -39.98M | -20.31M | -16.57M | |||||
Income Tax Expense | -125M | 14.42M | -2.61M | 19.75M | 36.45M | |||||
D&A | 19.91M | 28.55M | 81M | 75.57M | 78.78M | |||||
CAPEX | -37.8M | -45.87M | -30.08M | -15.16M | -10.64M | |||||
Net Income | 146M | 41.98M | 15.91M | 41.96M | -99.56M | |||||
EBT | 20.09M | 56.4M | 13.3M | 61.7M | -63.11M | |||||
Operating Income | 46.35M | 89.92M | 60.02M | 87.68M | -73.37M | |||||
Foreign | - | - | - | - | - |
- Stock Market
- Equities
- PCRX Stock
- Financials Pacira BioSciences, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
